Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
about
Hydroxychloroquine for systemic lupus erythematosus in adultsManagement of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesHydroxychloroquine-related retinal toxicityInflammatory etiopathogenesis of systemic lupus erythematosus: an updateChloroquine and hydroxychloroquine for cancer therapyJuvenile systemic lupus erythematosus: review of clinical features and managementUnmet medical needs in systemic lupus erythematosusTargeting dendritic cell function during systemic autoimmunity to restore toleranceImpact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney DiseaseIs hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.Management of cardiovascular complications in systemic lupus erythematosus.Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr MiceHydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DA S28 ESR)Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesChloroquine cardiomyopathy: beyond ocular adverse effects.Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.Chloroquine cardiomyopathy - a review of the literature.Belimumab for the treatment of systemic lupus erythematosus.Systemic lupus erythematosus: review of synthetic drugs.The role of autophagy induced by tumor microenvironment in different cells and stages of cancerTreatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.Antiphospholipid Syndrome during pregnancy: the state of the artAutophagy in autoimmune diseaseImportance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study.Inactive disease and remission in childhood-onset systemic lupus erythematosusUnexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionEarly treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.Metabolic regulation of organelle homeostasis in lupus T cellsReno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr miceMacroautophagy is deregulated in murine and human lupus T lymphocytes
P2860
Q24186197-F853B2F3-BB56-48DE-8C50-1A83F2DABF87Q26774815-FCA458AE-A4B2-4570-9D76-B9DBE7AB9CECQ26782822-F45A1BE2-09E1-4FE7-BA2D-A7BA81314F0FQ26796413-56351CE2-0482-4379-B59F-E90845B9F507Q26827797-2CA13170-B421-45C7-AFAA-A55FEB9F046BQ26849746-B4F5020D-D49C-4E1D-AA42-FD4D54410B7AQ27005906-936BEF28-DE95-4813-9519-7B53DB38ED87Q27687098-DE5B758A-0F2E-4095-B227-778B9C89D078Q28548561-2FB64C6C-A776-4184-B752-9A331899533CQ33667694-672E8D50-3D59-4DE1-B3F2-F89223A8B8A0Q33730536-F2F36E1F-95FC-4673-ADD4-0818B0400309Q33747286-041DDFDF-88DE-4704-A337-D03CD2808CD8Q33893517-23F85177-ADFF-4CEC-8845-7360E449F1C1Q33908254-3DB7DD77-970D-43C3-AE33-A877EE005E5BQ34003992-A9470004-7768-4BB1-86E4-0C75C3B44044Q34085682-97C75B6C-040B-49D8-8783-CB1C457A441DQ34162739-E437AE9D-B126-4823-A5AC-35D0A4915A09Q34169570-B53E17F8-014B-4EE1-94CF-EBEEC7E6B591Q34184151-16F3FFD0-EDAE-45F8-BD08-55D919037F4CQ34187282-1130D3A8-CD76-419E-A65C-BEC1121C9424Q34198175-B359A6C8-90C0-4256-935F-FC1EF0FA5276Q34315879-68C90FD7-9DEE-4554-9153-98F902DC9209Q34342236-146657AF-5F08-4A63-894A-E82988B52058Q34455827-E370F4B1-37EA-4F26-A20F-7F8DADA3ACD5Q34498515-EE3AA7C4-783C-4F26-B7F8-321470F923D4Q35257433-CB5F3CCE-DE07-44FE-98DA-5BE9B3A1598AQ35456519-686855FA-6F88-4D81-A562-80BF852F6C88Q35621012-2F142331-9C0D-49C5-B5F6-B7436F43E109Q35622999-0E4288AA-0CEA-4FAF-882C-0EC2D3663980Q35756040-86F43788-F62B-4F81-AA3D-EC4EC7041221Q35800364-175A309B-C81E-4D6E-91DE-C6184F60757AQ35840758-1A66E291-BBCD-48C7-86B0-CFD19F24D818Q35911531-E21CCEE1-84BB-4F79-964D-511C0FFD8228Q35915182-4A65C0FF-DB4F-4061-8C82-DEBA1DC333C0Q35998510-15155CD8-AF1C-416A-9A9A-FB77828E6570Q36126483-567600C8-326E-4EE1-A4C5-205C0106517CQ36153524-B558F87C-86D8-4C67-A5EE-66EDEF3CD0FBQ36177195-62AB8CBF-4A6C-4A78-8405-847EDB517AA9Q36186103-4BA6FA46-02F0-4E6E-9F6C-C46547E96427Q36194783-B0CF348D-3D3F-4FC3-AEB9-DE1D2A8C6FE6
P2860
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical efficacy and side eff ...... ematosus: a systematic review.
@en
Clinical efficacy and side eff ...... ematosus: a systematic review.
@nl
type
label
Clinical efficacy and side eff ...... ematosus: a systematic review.
@en
Clinical efficacy and side eff ...... ematosus: a systematic review.
@nl
prefLabel
Clinical efficacy and side eff ...... ematosus: a systematic review.
@en
Clinical efficacy and side eff ...... ematosus: a systematic review.
@nl
P50
P356
P1476
Clinical efficacy and side eff ...... ematosus: a systematic review.
@en
P2093
P Brito-Zeron
P356
10.1136/ARD.2008.101766
P407
P577
2010-01-01T00:00:00Z